Calithera Biosciences, Inc.
CALA · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | – | 85.3% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -1,165.7% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -1,180.4% | – | – |
| EPS Diluted | -7.94 | -31.16 | -26.2 | -36.5 |
| % Growth | 74.5% | -18.9% | 28.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |